The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients ; volume:136 ; number:15-16 ; day:17 ; month:6 ; year:2024 ; pages:458-464 ; date:8.2024
Wiener klinische Wochenschrift ; 136, Heft 15-16 (17.6.2024), 458-464, 8.2024

Creator: Platzer, Moritz
Totschnig, David
Karolyi, Mario
Clodi-Seitz, Tamara
Wenisch, Christoph
Zoufaly, Alexander

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00508-024-02377-7

URN: urn:nbn:de:101:1-2411022119030.964113869212

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Platzer, Moritz
Totschnig, David
Karolyi, Mario
Clodi-Seitz, Tamara
Wenisch, Christoph
Zoufaly, Alexander
SpringerLink (Online service)

Other Objects (12)

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study

Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study

Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database

The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis

Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study

Remdesivir: A Review in COVID-19

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir

$Untersuchung der Nephrotoxizität von Remdesivir $in$ $vitro$$

Untersuchung der Nephrotoxizität von Remdesivir $in$ $vitro$

Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned

Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V

Correction to: Remdesivir: A Review in COVID-19

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study

Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study

Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database

The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis

Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study

Remdesivir: A Review in COVID-19

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir

$Untersuchung der Nephrotoxizität von Remdesivir $in$ $vitro$$

Untersuchung der Nephrotoxizität von Remdesivir $in$ $vitro$

Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned

Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V

Correction to: Remdesivir: A Review in COVID-19

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study

Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study

Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database

The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis

Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study

Remdesivir: A Review in COVID-19

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir

$Untersuchung der Nephrotoxizität von Remdesivir $in$ $vitro$$

Untersuchung der Nephrotoxizität von Remdesivir $in$ $vitro$

Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned

Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V

Correction to: Remdesivir: A Review in COVID-19

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study

Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study

Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database

The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis

Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study

Remdesivir: A Review in COVID-19

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir

Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)

Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned

Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V

Correction to: Remdesivir: A Review in COVID-19

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study

Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study

Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database

The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis

Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study

Remdesivir: A Review in COVID-19

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir

Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)

Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned

Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V

Correction to: Remdesivir: A Review in COVID-19

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study

Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study

Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database

The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis

Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study

Remdesivir: A Review in COVID-19

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir

Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)

Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned

Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V

Correction to: Remdesivir: A Review in COVID-19

Related objects

Reset password